首页 › 基金 › TCG Crossover Management, LLC › CGEM
TCG Crossover Management, LLC 对 CGEM 的持仓历史
CULLINAN THERAPEUTICS INC · 医疗保健
TCG Crossover Management, LLC 在 Q3 2026 的 13F 申报中披露持有 CGEM(CULLINAN THERAPEUTICS INC)406,786 股,市值约 US$6.2M,约占其申报组合的 0.18%,在其申报持仓中市值排名第 45 位。 TCG Crossover Management, LLC 最近 3 个申报季度中有 3 个季度披露了 CGEM 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
TCG Crossover Management, LLC 对 CGEM 的持仓演变
TCG Crossover Management, LLC 于 Q1 2026 首次披露 CGEM 持仓:406,786 股(约 US$5.8M)。 该持仓在 Q2 2026 达到峰值 406,786 股,市值约 US$7.4M。 在 3 次申报中,TCG Crossover Management, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 406,786 股、市值约 US$6.2M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 406.79K | $5.78M | 新进 |
| Q2 2026 | 406.79K | $7.41M | 持有 |
| Q3 2026 | 406.79K | $6.24M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CGEM 与 13F 数据
CGEM(CULLINAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 CGEM,申报仓位最大的包括:MPM BioImpact LLC (US$177.2M), Lynx1 Capital Management LP (US$163.2M), BVF INC/IL (US$104.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CGEM 的基金
- MPM BioImpact LLC 9.73M 股 · $177.21M · Q2 2026
- Lynx1 Capital Management LP 8.96M 股 · $163.23M · Q2 2026
- BVF INC/IL 5.75M 股 · $104.72M · Q2 2026
- Kynam Capital Management, LP 3.11M 股 · $47.80M · Q3 2026
- RTW INVESTMENTS, LP 2.36M 股 · $36.29M · Q3 2026
- Siren, L.L.C. 1.79M 股 · $27.53M · Q3 2026
- Venrock Adviser, LLC 1.38M 股 · $25.13M · Q2 2026
- Blue Owl Capital Holdings LP 1.40M 股 · $21.49M · Q3 2026
- Affinity Asset Advisors, LLC 875.76K 股 · $13.44M · Q3 2026
- BOONE CAPITAL MANAGEMENT LLC 704.44K 股 · $12.83M · Q2 2026
- Elmind Capital, LP 690.00K 股 · $12.56M · Q2 2026
- TWIN FOCUS CAPITAL PARTNERS, LLC 595.49K 股 · $9.14M · Q3 2026
更多关于 TCG Crossover Management, LLC
常见问题
How long has TCG Crossover Management, LLC held CGEM?
TCG Crossover Management, LLC has disclosed CGEM holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is TCG Crossover Management, LLC's current position in CGEM?
As of Q3 2026, TCG Crossover Management, LLC holds 406.79K shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $6.24M, representing 0.18% of its reported portfolio and ranking #45.
Has TCG Crossover Management, LLC been buying or selling CGEM?
In the latest 13F filing (Q3 2026), TCG Crossover Management, LLC held unchanged its position in CGEM. The position peaked in Q2 2026 at 406.79K shares.
Which other funds hold CGEM?
Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, BVF INC/IL, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.